Search Results - M. A. Morozova

Refine Results
  1. 1

    Options of dyslipidemia treatment at non-alcoholic fatty liver disease by M. V. Mayevskaya, M. A. Morozova

    Published 2018-08-01

    Aim of review. To consider different treatment options for dyslipidemia in non-alcoholic fatty liver disease (NAFLD). Summary. NAFLD occurs in 20-30% of adult population. In the Russian Federation its rate is estimated as high as 37,1%. In the most of NAFLD cases severe disorder of lipid metabolism...

    Full description

    Get full text
    Article
  2. 2

    Chronic hepatitis C course at elderly and therapeutic approach by M. V. Mayevskaya, M. A. Morozova

    Published 2011-02-01

    The aim of review. To discuss features of course of chronic hepatitis C virus infection at elderly, efficacy and safety of antiviral treatment of patients of this age group.Original positions. In every day clinical practice elderly patients with chronic hepatitis C are extremely rarely considered as...

    Full description

    Get full text
    Article
  3. 3

    Algorithm of management of patient with alcohol-induced liver disease by M. V. Mayevskaya, M. A. Morozova

    Published 2011-02-01

    The aim of review. To present main pathogenic aspects of development of alcohol-induced liver disease (ALD), principles of diagnostics and treatment of this disease.Original positions. The alcohol-induced liver disease includes some variants of parenchymal damage caused by regular alcohol intake: st...

    Full description

    Get full text
    Article
  4. 4

    Leading causes of fever in patients with liver function disorders by V. T. Ivashkin, M. A. Morozova, M. V. Mayevskaya

    Published 2010-02-01

    The aim of review. Analysis of literature data on the possible causes of fever at patients with disorders of liver function. Article presents pathophysiological mechanisms of development of fever. The algorithm of assessment of patient with disorder of liver function and fever is submitted.Original...

    Full description

    Get full text
    Article
  5. 5

    Hepatopulmonary syndrome by V. T. Ivashkin, M. A. Morozova, M. V. Mayevskaya

    Published 2018-08-01

    The purpose of this paper is to analyze the data available in the literature on the problems associated with the identification of the hepatopulmonary syndrome (HPS), its diagnosis, pathogenesis, clinical features, and possible treatment options. According to the current literature, HPS is a complic...

    Full description

    Get full text
    Article
  6. 6

    Modern approach to automation of internal control of quality and safety of medical care by S. Y. Morozov, M. A. Morozova, L. E. Morozova

    Published 2022-03-01

    Introduction. Heads of medical organizations operating under the Moscow Healthcare Department are the ones who take care of internal control of quality and safety of medical care [1-7]. However, once the healthcare system in Moscow switched to the Unified Medical Information Analysis System (UMIAS),...

    Full description

    Get full text
    Article
  7. 7

    Bioactive Xanthone C-glycoside Derivatives – QSAR Approach by V. N. Aksenova, M. A. Morozova, A. V. Syroeshkin

    Published 2023-05-01

    Introduction. Xanthone glycosides have unique structures and properties. Many efforts focus on the search for C-glycoside derivatives of mangiferin with higher bioavailability. The application of the QSAR approach allows for the optimization of the search for novel xanthone derivatives with the desi...

    Full description

    Get full text
    Article
  8. 8

    Modern modes of chronic hepatitis B treatment in daily clinical practice by M. V. Mayevskaya, M. A. Morozova, S. A. Ondos, V. T. Ivashkin

    Published 2014-11-01

    The aim of review and clinical case. To bring modern standards of antiviral therapy (AVT) of chronic hepatitis B (CHB) and possible mistakes at assessment of medical tactics to focus of general practitioners.Summary. Chronic hepatitis B still remains one of the most actual problems in hepatology. Th...

    Full description

    Get full text
    Article
  9. 9

    получавших лечение. При этом наблюдается значительно меньшая частота развития побочных эффекModern therapeutic modes of treatment of autoimmune hepatitis... by V. T. Ivashkin, M. A. Morozova, M. V. Mayevskaya, A. O. Buyeverov

    Published 2009-08-01

    The aim of review. To present the standard and alternative therapeutic modes used at treatment of autoimmune hepatitis (AIH).Original positions. Autoimmune hepatitis is a chronic inflammatory disease of the liver of the unknown etiology, accompanied by elevation of serum transaminase level, hypergam...

    Full description

    Get full text
    Article
  10. 10

    Modern modes of chronic hepatitis C treatment by V. T. Ivashkin, M. V. Mayevskaya, M. A. Morozova, Ye. O. Lyusina

    Published 2012-02-01

    The aim of review. To highlight up-to-date modes of chronic hepatitis C treatment.Original positions. Nowadays conventional «gold standard» treatment of chronic HCV-infection is antiviral therapy by pegilated interferon and ribavirin combination. Recently principles of antiviral treatment were serio...

    Full description

    Get full text
    Article
  11. 11

    Herbal medications in the treatment of hepatitis C by V. T. Ivashkin, M. A. Morozova, M. V. Mayevskaya, Ye. A. Fedos’ina

    Published 2009-06-01

    The aim of review. To present results of randomized studies of efficacy of agents, containing medical herbs, in the treatment of hepatitis C and expediency of their application in these patients.Original positions. Efficacy of treatment of patients with viral hepatitis C by traditional Chinese herbs...

    Full description

    Get full text
    Article
  12. 12

    Efficacy of Physiologically Active nutrients in the Treatment of Asthenic Disorders in Patients with Chronic Diffuse Liver Diseases by M. V. Mayevskaya, M. A. Morozova, A. G. Beniashvili, V. D. Lunkov, V. T. Ivashkin

    Published 2019-09-01

    Over the period after an exacerbation of chronic liver diseases, patients often retain common symptoms (weakness or fatigue, bad mood, sleep disorder, vegetative disorders — asthenic syndrome). In the context of prevention and treatment of these symptoms, such nutraceutical products as enriched food...

    Full description

    Get full text
    Article
  13. 13

    Retrospective review of methodological foundations for the new monograph «Spectrometry in the near infrared regioN» by O. V. Soboleva, T. E. Elizarova, A. Yu. Arik, A. M. Koldina, M. A. Morozova

    Published 2018-02-01

    The new pharmacopoeial monograph «Spectrometry in the near infrared region» reflects the results of a difficult path traversed from the development of measurement and analytical techniques to the introduction of NIR spectroscopy in the practice of quality control. This review discusses the new monog...

    Full description

    Get full text
    Article
  14. 14

    Risk factors of development of hepatocellular carcinoma by V. T. Ivashkin, M. A. Morozova, M. V. Mayevskaya, I. A. Sokolina, Ye. N. German, M. V. Bundina

    Published 2009-02-01

    The aim of review. To draw attention of general practitioners to the risk factors of hepatocellular carcinoma (HCC) development, to define group of patients with high probability of development of this tumor, to outline algorithm of screening diagnostics for patients of high risk group.Original posi...

    Full description

    Get full text
    Article
  15. 15

    Impulsivity in schizophrenia: phenomenology and research approaches by T. A. Lepilkina, M. A. Morozova, G. E. Rupchev, D. S. Burminskiy, A. G. Beniashvili, S. S. Potanin, A. A. Kibitov

    Published 2025-06-01

    Impulsivity in schizophrenia is not a solid phenomenon either at the level of behavior or from the point of view of psychological mechanisms and underlying physiology. Some research approaches are considered in the article, and three types of impulsivity were identified based on the difference in re...

    Full description

    Get full text
    Article
  16. 16

    The modern features of the clinics, diagnostics and treatment of patients with epidermolysis bullosa by L. A. Yusupovа, E. I. Yunusovа, Z. Sh. Garaeva, G. I. Mavlyutova, M. A. Morozova

    Published 2021-06-01

    The article presents information on epidermolysis bullosa, a rare genetic skin disease caused by mutations of several genes responsible for the synthesis of structural proteins of the skin. The pathogenic mechanisms causing the development of epidermolysis bullosa and deterioration of the clinical s...

    Full description

    Get full text
    Article
  17. 17

    Comparative analysis of the efficacy of seniprutug (BCD-180) and adalimumab in the treatment of active radiographic axial spondyloarthritis: results of a systematic review and matc... by A. M. Lila, T. V. Dubinina, D.  G. Tolkacheva, K. V. Sapozhnikov, N. A. Sableva, M. A. Morozova, P. S. Pukhtinskaia

    Published 2024-04-01

    Objective: to compare the clinical efficacy of seniprutug (BCD-180) and adalimumab (ADA) in the treatment of adults with active radiographic axial spondyloarthritis (r-axSpA).Materials and methods. Based on the results of a previously conducted systematic review, an unanchored matching-adjusted indi...

    Full description

    Get full text
    Article
  18. 18

    Effectiveness of a virtual reality relaxation to correct symptoms of depression, anxiety, emotional and cognitive disorders in patients with heart failure by Yu. F. Osmolovskaya, A. A. Petrukhina, Yu. O. Aksenova, I. V. Zhirov, A. G. Beniashvili, M. A. Morozova, S. N. Tereshchenko

    Published 2024-08-01

    Aim. To study the effectiveness of virtual reality (VR) relaxation to correct symptoms of depression, anxiety, emotional and cognitive disorders in patients with heart failure (HF).Material and methods. The study included 100 patients with HF aged 21 to 83 years. A main group of 58 people was random...

    Full description

    Get full text
    Article
  19. 19

    Cognitive impairment in chronic heart failure. How new therapeutic options for the treatment of chronic heart failure affect cognitive function? by Y. O. Aksenova, Y. F. Osmolovskaya, A. A. Petrukhina, I. V. Zhirov, A. G. Beniashvili, S. N. Tereshchenko, M. A. Morozova

    Published 2024-03-01

    Heart failure is a serious chronic illness and a global healthcare problem. Patients with heart failure have increased hospital readmission rates and mortality around the world. Heart failure often coexists with comorbidities of which cognitive impairment is particularly important. Сognitive impairm...

    Full description

    Get full text
    Article
  20. 20

    The possibility of using laser methods for the quality control of highly diluted liquid pharmaceuticals by A. V. Syroeshkin, T. V. Pleteneva, M. A. Morozova, E. V. Uspenskaya, O. V. Titorovich, E. V. Lesnikov, V. I. Dobrovolsky

    Published 2018-02-01

    Processing of interferon gamma antibodies, which involves gradual reduction of the concentration, induces the formation of deuterium-stabilized giant heterophase clusters (GHCs) of water characterized by the specific size spectrum and kinetics of formation/decay. An investigation into the formation/...

    Full description

    Get full text
    Article